MedPath

Assessment of a Modified Minimally Invasive Esophagectomy

Completed
Conditions
Esophageal Cancer
Registration Number
NCT04219410
Lead Sponsor
Kaiser Permanente
Brief Summary

This is a retrospective case series of a novel fully minimally invasive esophagectomy procedure for patients with primary esophageal cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
142
Inclusion Criteria
  • patient with primary esophageal cancer of any cell type
  • underwent the novel minimally invasive esophagectomy procedure at the Kaiser Permanente Northern California Oakland Medical Center by one of the study author-surgeons
Exclusion Criteria
  • non-elective procedure
  • less than 90 days of post-discharge follow-up

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hospital length of stayThrough study completion, an average of 2.9 years

Hospital length of stay

Secondary Outcome Measures
NameTimeMethod
Number of patients with inpatient mortalityThrough study completion, an average of 2.9 years

Number of patients with inpatient mortality

90-day total mortality90 days post discharge

90-day total mortality

Number of patients with hospital readmission within 30 days30 days post discharge

Number of patients with hospital readmission within 30 days

Feeding tube placementIntra-operatively

Feeding tube placement

Number of patients with complicationsHospital stay and 30 days post discharge

Number of patients with medical and surgical complications both inpatient and post-discharge

Intensive care unit length of stayThrough study completion, an average of 2.9 years

Intensive care unit length of stay

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.